These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32846099)

  • 1. Multiparametric prostate MRI-based intensity-modulated radiation therapy guided by prostatic calcifications.
    Kao J; Karwowski P; Pettit J; Barney AK; Atalla C
    Br J Radiol; 2020 Dec; 93(1116):20200571. PubMed ID: 32846099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraprostatic calcifications as natural fiducial markers in image-guided radiotherapy for prostate cancer].
    Sbai A; Thariat J; Tachfouti N; Pan Q; Lagrange JL
    Cancer Radiother; 2014 Dec; 18(8):740-4. PubMed ID: 25451671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geometric discrepancy of image-guided radiation therapy in patients with prostate cancer without implanted fiducial markers using a commercial pseudo-CT generation method.
    Kan H; Eguchi Y; Tsuchiya T; Kondo T; Kitagawa Y; Mekata Y; Fukuma H; Yoshida R; Kasai H; Kunitomo H; Hirose Y; Shibamoto Y
    Phys Med Biol; 2019 Mar; 64(6):06NT01. PubMed ID: 30695772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.
    Nakamura K; Mizowaki T; Inokuchi H; Ikeda I; Inoue T; Kamba T; Ogawa O; Hiraoka M
    Int J Clin Oncol; 2018 Feb; 23(1):158-164. PubMed ID: 28756594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial.
    Zapatero A; Roch M; Castro Tejero P; Büchser D; Martin de Vidales C; González S; Rodríguez P; San Jose LA; Celada G; Murillo MT
    Br J Radiol; 2022 Mar; 95(1131):20210683. PubMed ID: 34538073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial.
    Murray JR; Tree AC; Alexander EJ; Sohaib A; Hazell S; Thomas K; Gunapala R; Parker CC; Huddart RA; Gao A; Truelove L; McNair HA; Blasiak-Wal I; deSouza NM; Dearnaley D
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):715-724. PubMed ID: 31812718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis.
    Tamihardja J; Schortmann M; Lawrenz I; Weick S; Bratengeier K; Flentje M; Guckenberger M; Polat B
    Strahlenther Onkol; 2021 Feb; 197(2):124-132. PubMed ID: 32833036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intra- or periprostatic calcifications in image-guided radiotherapy for prostate cancer.
    Hanna SA; Neves-Junior WF; Marta GN; Haddad CM; da Silva JL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1208-16. PubMed ID: 21640492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.
    Takeda K; Takai Y; Narazaki K; Mitsuya M; Umezawa R; Kadoya N; Fujita Y; Sugawara T; Kubozono M; Shimizu E; Abe K; Shirata Y; Ishikawa Y; Yamamoto T; Kozumi M; Dobashi S; Matsushita H; Chida K; Ishidoya S; Arai Y; Jingu K; Yamada S
    Radiat Oncol; 2012 Jul; 7():105. PubMed ID: 22770471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.
    Zapatero A; Roch M; Büchser D; Castro P; Fernández-Banda L; Pozo G; Liñán O; Martin de Vidales C; Cruz-Conde A; García-Vicente F
    Clin Transl Oncol; 2017 Sep; 19(9):1161-1167. PubMed ID: 28374321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
    Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of intensity-modulated radiation therapy for prostate cancer: History, clinical results and future directions.
    Hatano K; Tohyama N; Kodama T; Okabe N; Sakai M; Konoeda K
    Int J Urol; 2019 Aug; 26(8):775-784. PubMed ID: 31115116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients.
    Napieralska A; Majewski W; Kulik R; Głowacki G; Miszczyk L
    Radiat Oncol; 2018 Nov; 13(1):235. PubMed ID: 30482212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-guided dose-escalated radiation therapy for localized prostate cancer with helical tomotherapy.
    Barelkowski T; Wust P; Kaul D; Zschaeck S; Wlodarczyk W; Budach V; Ghadjar P; Beck M
    Strahlenther Onkol; 2020 Mar; 196(3):229-242. PubMed ID: 31873779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
    Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
    Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 trial of guideline-based postoperative image guided intensity modulated radiation therapy for prostate cancer: Toxicity, biochemical, and patient-reported health-related quality-of-life outcomes.
    Berlin A; Cho E; Kong V; Howell KJ; Lao B; Craig T; Bayley A; Chung P; Gospodarowicz M; Warde P; Catton C; Bristow RG; Ménard C
    Pract Radiat Oncol; 2015; 5(5):e473-e482. PubMed ID: 25899220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial.
    Tøndel H; Lund JÅ; Lydersen S; Wanderås AD; Aksnessæther B; Jensen CA; Kaasa S; Solberg A
    Radiother Oncol; 2018 Feb; 126(2):229-235. PubMed ID: 29398152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.